drugset / Trial / NCT05396235
A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics when MT-3921 or a placebo is intravenously given to Japanese healthy adult male subjects
Timeline
- Start
- 2022-08-03
- Primary completion
- 2022-12-24
- Completion
- 2022-12-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UNASNEMAB | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.